日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ASO drug olezarsen targets familial chylomicronemia syndrome

ASO药物olezarsen靶向治疗家族性乳糜微粒血症综合征。

Jin, Jing; Nguyen, Le Tra Giang; Tawfik, Sherouk M; Armanios, Beshoy; Zhong, Xiao-Bo

Impact on efficacy of target reduction of two FDA-approved ASO drugs by intracellular glucose levels in in vitro cell models.

细胞内葡萄糖水平对两种 FDA 批准的 ASO 药物靶点降低的疗效在体外细胞模型中的影响

Nguyen Le Tra Giang, Tawfik Sherouk M, Jin Jing, Durwin Andrea, Zhong Xiao-Bo

Visualization of CYP3A4 expression at both mRNA and protein levels simultaneously at single cell resolution in various conditions using RNAscope combined with immunofluorescence.

利用 RNAscope 结合免疫荧光技术,在各种条件下以单细胞分辨率同时可视化 CYP3A4 在 mRNA 和蛋白质水平上的表达。

Jin Jing, Tawfik Sherouk M, Nguyen Le Tra Giang, Armanios Beshoy, Zhong Xiao-Bo

Correlations of Long Noncoding RNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism.

长链非编码RNA HNF4A-AS1替代转录本与肝脏疾病和药物代谢的相关性

Jin Jing, Nguyen Le Tra Giang, Wassef Andrew, Sadek Ragui, Schmitt Timothy M, Guo Grace L, Rasmussen Theodore P, Zhong Xiao-Bo